Gempharmatech LLC

San Diego, CA

UEI
H42SCKKGRTU3
CAGE
98AV0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
11175 Flintkote Ave b, San Diego, CA 92121, USA
Website
gempharmatech.com
Founded
2017
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Gempharmatech LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Ncats: service: evaluation of a lead nnmt inhibitor in humanized mouse models of chronic kidney disease: severable Contract · 75N98026P01587 Office of Logisitics and Acquisition Operations $89,040
Safety evaluation of YC1 in HSULT1A1 and MSULT1A1 mice. Contract · 75N95025P00413 National Institute on Drug Abuse $58,936
Saksena hyterozygote generation of PGP/MDR1A floxed live mice gempharmatech LLC Contract · 36C25224C0035 Veterans Integrated Service Network 12 $12,850
Live animal production- KREMEN1-flox mice Contract · 75N95D24P00092 National Institute on Aging $13,510
Developing humanized mouse models for nnmt and SULT1A1 Contract · 75N95023P00824 National Institute on Drug Abuse $249,168

About Gempharmatech LLC

Gempharmatech LLC is a foreign-owned, for-profit biotechnology company located in San Diego, California, specializing in the development of advanced mouse models for preclinical research. Registered in the System for Award Management (SAM) since December 30, 2021, with registration valid until May 13, 2026, the company focuses on creating sophisticated genetic modifications in mice to support drug discovery and development across various medical research domains.

Gempharmatech LLC has consistently secured federal contract awards primarily from National Institutes of Health (NIH) agencies, including the National Center for Advancing Translational Sciences (NCATS), National Institute of Child Health and Human Development (NICHD), National Institute on Aging (NIA), National Institute of Allergy and Infectious Diseases (NIAID), and Veterans Integrated Service Network 12. Their federal contracts, predominantly fixed-price purchase orders ranging from $11,930 to $249,167.58, involve generating highly specialized mouse models such as conditional knockouts, humanized mice, and floxed mouse lines. These models are designed for specific research purposes, including developing mouse models with modified proteins like SULT1A1, NNMT, Kremen1, and PGP/MDR1A, and conducting tolerability and safety studies. None of their contracts have utilized set-aside designations, and they have been awarded contracts to develop mouse models that support preclinical drug discovery, pharmacokinetic/pharmacodynamic experiments, and targeted research across various medical disciplines.

Quick answers

What is Gempharmatech LLC's UEI?

Gempharmatech LLC's Unique Entity ID (UEI) in SAM.gov is H42SCKKGRTU3.

What is Gempharmatech LLC's CAGE code?

Gempharmatech LLC's CAGE code is 98AV0.

What is Gempharmatech LLC's primary NAICS code?

Gempharmatech LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Gempharmatech LLC located?

Gempharmatech LLC's physical address in SAM.gov is 11175 Flintkote Ave b, San Diego, CA 92121, USA.

Is Gempharmatech LLC registered in SAM.gov?

Yes. Gempharmatech LLC's SAM.gov registration is active through April 23, 2027.

What is Gempharmatech LLC's most recent federal award?

Gempharmatech LLC's most recent federal contract award is Ncats: service: evaluation of a lead nnmt inhibitor in humanized mouse models of chronic kidney disease: severable (75N98026P01587), from Office of Logisitics and Acquisition Operations, on September 11, 2026.

On GovTribe

See Gempharmatech LLC's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors